{"disease":{"id":"alcohol","name":"alcohol"},"drugs":{"marketed":[{"drug_id":"nalmefene","indication_name":"Alcoholism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Revex","generic_name":"NALMEFENE","company_name":"Hikma","drug_phase":"marketed","molecular_target":"Kappa-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":55,"revenue":"400","mechanism":""},{"drug_id":"diazepam","indication_name":"Alcohol withdrawal delirium","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valium","generic_name":"diazepam","company_name":"Generic (originally Roche)","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2","drug_class":"Benzodiazepine [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"diazepam","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valium","generic_name":"diazepam","company_name":"Generic (originally Roche)","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2","drug_class":"Benzodiazepine [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"antizol","indication_name":"Accidental poisoning by methyl alcohol","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Antizol","company_name":"Amgen","drug_phase":"marketed","molecular_target":"Alcohol dehydrogenase, Alcohol dehydrogenase","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"sulfiram","indication_name":"Alcoholism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tetrucid","generic_name":"SULFIRAM","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Tetrucid works by inhibiting the enzyme aldehyde dehydrogenase, which breaks down alcohol into a less toxic compound."},{"drug_id":"fomepizole","indication_name":"Accidental poisoning by methyl alcohol","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Antizol","generic_name":"FOMEPIZOLE","company_name":"Par Pharm Inc","drug_phase":"marketed","molecular_target":"Alcohol dehydrogenase","drug_class":"Antidote [EPC]","quality_score":10,"revenue":null,"mechanism":"Antizol works by competitively inhibiting the enzyme alcohol dehydrogenase, which is responsible for converting toxic alcohols into their more toxic metabolites."},{"drug_id":"undecanoate","indication_name":"Toxic damage from alcohol or heavy metals","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tlando","generic_name":"UNDECANOATE","company_name":"Tolmar","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":55,"revenue":null,"mechanism":"Tlando works by increasing testosterone levels in the body."},{"drug_id":"chlordiazepoxide","indication_name":"Alcohol withdrawal delirium","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chlordiazepoxide Hydrochloride","generic_name":"CHLORDIAZEPOXIDE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Benzodiazepine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"chlordiazepoxide","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chlordiazepoxide Hydrochloride","generic_name":"CHLORDIAZEPOXIDE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Benzodiazepine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"acamprosate","indication_name":"Alcoholism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Campral","generic_name":"ACAMPROSATE","company_name":"Allergan/AbbVie","drug_phase":"marketed","molecular_target":"GABA-A receptor alpha-1/beta-3/gamma-2","drug_class":"acamprosate","quality_score":60,"revenue":null,"mechanism":"Campral works by modulating the activity of the GABA-A receptor, a key neurotransmitter system involved in regulating alcohol cravings and withdrawal symptoms."},{"drug_id":"15-valent-pneumococcal-conjugate-vaccine-pcv15","indication_name":"Prevention of invasive pneumococcal disease caused by 15 serotypes of Streptococcus pneumoniae in adults 18 years of age and older with alcohol use disorder.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"15-valent pneumococcal conjugate vaccine (PCV15)","generic_name":"15-valent-pneumococcal-conjugate-vaccine-pcv15","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"naltrexon","indication_name":"Alcoholism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naltrexon","company_name":"Institute of Liver and Biliary Sciences, India","drug_phase":"marketed","molecular_target":"Neuronal acetylcholine receptor subunit alpha-7, Cytochrome P450 2D6, Delta-type opioid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"clorazepate","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tranxene","generic_name":"clorazepate","company_name":"Ajenat Pharms","drug_phase":"marketed","molecular_target":"GABA-A receptor alpha-1/beta-2/gamma-2","drug_class":"Benzodiazepine","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"diazepam-2mg-encapsulated-tab","indication_name":"Symptomatic relief of acute alcohol withdrawal","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Diazepam 2Mg encapsulated Tab","company_name":"The University of Hong Kong","drug_phase":"marketed","molecular_target":"GABA-A receptor (allosteric modulator)","drug_class":"Benzodiazepine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"clomethiazole","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Emineurina","generic_name":"CLOMETHIAZOLE","company_name":"","drug_phase":"discontinued","molecular_target":"GABA-A receptor alpha-1/beta-3/gamma-2","drug_class":"clomethiazole","quality_score":0,"revenue":null,"mechanism":"Emineurina works by enhancing the activity of the neurotransmitter GABA, which helps to calm excessive brain activity."},{"drug_id":"disulfiram","indication_name":"Alcoholism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Antabuse","generic_name":"DISULFIRAM","company_name":"","drug_phase":"marketed","molecular_target":"Lysyl oxidase homolog 4","drug_class":"Aldehyde Dehydrogenase Inhibitor [EPC]","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"prevenar-20","indication_name":"Prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, and 23F in adults 18 years of age and older with alcohol use disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prevenar 20","generic_name":"prevenar-20","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae","drug_class":"Vaccine","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"prevenar-20","indication_name":"Prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, and 23F in adults 50 years of age and older with alcohol use disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prevenar 20","generic_name":"prevenar-20","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae","drug_class":"Vaccine","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"prevenar-20","indication_name":"Prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, and 23F in adults 65 years of age and older with alcohol use disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prevenar 20","generic_name":"prevenar-20","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae","drug_class":"Vaccine","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"ppsv23","indication_name":"Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with alcohol use disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ppsv23","generic_name":"ppsv23","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae","drug_class":"Vaccine","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with chronic heart disease, chronic lung disease, diabetes mellitus, or alcoholism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"resmetirom","indication_name":"Noncirrhotic Nonalcoholic Steatohepatitis (NASH)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"RESMETIROM","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Thyroid Hormone Receptor beta Agonist [EPC]","quality_score":30,"revenue":null,"mechanism":null}],"pipeline":[{"drug_id":"pf-05221304","indication_name":"Nonalcoholic fatty liver disease (NAFLD)","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-05221304","generic_name":"pf-05221304","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"Acetyl-CoA carboxylase (ACC1 and ACC2)","drug_class":"Acetyl-CoA carboxylase inhibitor","quality_score":27,"revenue":null,"mechanism":"Selective inhibitor of acetyl-CoA carboxylase (ACC1/ACC2) that reduces hepatic lipogenesis and promotes fatty acid oxidation."},{"drug_id":"pf-05221304","indication_name":"Nonalcoholic steatohepatitis (NASH)","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-05221304","generic_name":"pf-05221304","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"Acetyl-CoA carboxylase (ACC1 and ACC2)","drug_class":"Acetyl-CoA carboxylase inhibitor","quality_score":27,"revenue":null,"mechanism":"Selective inhibitor of acetyl-CoA carboxylase (ACC1/ACC2) that reduces hepatic lipogenesis and promotes fatty acid oxidation."}],"offLabel":[],"totalMarketed":22,"totalPipeline":2},"trials":{"data":[{"nct_id":"NCT05865847","title":"Socioeconomic Differences in Alcohol Harm in Finland in a Nationwide Cohort Study","phase":"","overall_status":"UNKNOWN","enrollment_count":3950000,"lead_sponsor_name":"Finnish Institute for Health and Welfare","has_results":false},{"nct_id":"NCT07514377","title":"JiGenerations Health Cohort Study：Parental Exposure and Intergenerational Health in China","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"National Research Institute for Family Planning, China","has_results":false},{"nct_id":"NCT04474444","title":"Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP)","phase":"","overall_status":"COMPLETED","enrollment_count":55000,"lead_sponsor_name":"University of Lincoln","has_results":false},{"nct_id":"NCT04973202","title":"Portrayal of Hospital Alcohol Detoxification in France","phase":"","overall_status":"COMPLETED","enrollment_count":50000,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05252221","title":"Alcohol Telemedicine Consultation in Primary Care (ATC)","phase":"NA","overall_status":"COMPLETED","enrollment_count":41843,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT01273220","title":"National Epidemiologic Survey on Alcohol and Related Conditions-III","phase":"","overall_status":"COMPLETED","enrollment_count":36309,"lead_sponsor_name":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","has_results":false},{"nct_id":"NCT03262259","title":"Evaluation of Global Smart Drinking Goals Initiative","phase":"NA","overall_status":"RECRUITING","enrollment_count":36000,"lead_sponsor_name":"HBSA","has_results":false},{"nct_id":"NCT06907563","title":"Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Universität des Saarlandes","has_results":false},{"nct_id":"NCT01398319","title":"Prevention of Alcohol Related Incidents in the US Air Force","phase":"NA","overall_status":"COMPLETED","enrollment_count":26231,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT06486688","title":"Centralized Virtual SBIRT for Pediatric Primary Care","phase":"NA","overall_status":"RECRUITING","enrollment_count":22320,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT03151473","title":"Longitudinal Observational Study Of Chinese With NAFLD/NASH","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Humanity and Health Research Centre","has_results":false},{"nct_id":"NCT07241195","title":"A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":20000,"lead_sponsor_name":"The Affiliated Hospital of Hangzhou Normal University","has_results":false},{"nct_id":"NCT05160233","title":"Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":18430,"lead_sponsor_name":"Kaiser Permanente","has_results":true},{"nct_id":"NCT07135115","title":"Targeting Lifestyle to Improve Colorectal Cancer Screening","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":16000,"lead_sponsor_name":"Norwegian Institute of Public Health","has_results":false},{"nct_id":"NCT04099147","title":"Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.","phase":"","overall_status":"UNKNOWN","enrollment_count":14046,"lead_sponsor_name":"Instituto de Investigación Marqués de Valdecilla","has_results":false},{"nct_id":"NCT03847116","title":"Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease","phase":"","overall_status":"COMPLETED","enrollment_count":14014,"lead_sponsor_name":"Ningbo No. 1 Hospital","has_results":false},{"nct_id":"NCT04248023","title":"Screening and Management of Unhealthy Alcohol Use in Primary Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":13680,"lead_sponsor_name":"Virginia Commonwealth University","has_results":false},{"nct_id":"NCT05550688","title":"Weight Gain After Smoking Cessation and NAFLD","phase":"","overall_status":"COMPLETED","enrollment_count":12941,"lead_sponsor_name":"Ningbo No. 1 Hospital","has_results":false},{"nct_id":"NCT07336563","title":"ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Jarosław Drobnik","has_results":false},{"nct_id":"NCT04442334","title":"The European NAFLD Registry","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Newcastle University","has_results":false},{"nct_id":"NCT07305701","title":"Cohort Study on Medical Students' Mental Health","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Centre Hospitalier Régional d'Orléans","has_results":false},{"nct_id":"NCT03525769","title":"Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT07430787","title":"Hyponatremia - Complications, Prognosis, Epidemiology in Finnish Tertiary Care","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"University of Turku","has_results":false},{"nct_id":"NCT04647409","title":"Screening for NAFLD in Flanders","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Hasselt University","has_results":false},{"nct_id":"NCT06676059","title":"SMART-r: Substance Monitoring and Active Relapse Tracking Repository","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"National Institute on Drug Abuse (NIDA)","has_results":false},{"nct_id":"NCT06552741","title":"Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"National Institute on Drug Abuse (NIDA)","has_results":false},{"nct_id":"NCT04861792","title":"Michigan SPARC Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":9590,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT04282915","title":"Reducing Stigma Among Healthcare Providers (RESHAPE-cRCT)","phase":"NA","overall_status":"COMPLETED","enrollment_count":8705,"lead_sponsor_name":"George Washington University","has_results":false},{"nct_id":"NCT05546086","title":"BeijngFH Health Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":8103,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT02231840","title":"NIAAA Natural History Protocol","phase":"","overall_status":"RECRUITING","enrollment_count":7500,"lead_sponsor_name":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","has_results":false},{"nct_id":"NCT04743024","title":"TREAT Child Alcohol Use Disorder (C-AUD) in Eastern Uganda","phase":"","overall_status":"UNKNOWN","enrollment_count":7188,"lead_sponsor_name":"University of Bergen","has_results":false},{"nct_id":"NCT04949711","title":"Impacts of Subsidized Ridesharing on Drunk Driving, Alcohol Consumption, and Mobility","phase":"NA","overall_status":"COMPLETED","enrollment_count":7034,"lead_sponsor_name":"Columbia University","has_results":true},{"nct_id":"NCT03308916","title":"Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers","phase":"NA","overall_status":"RECRUITING","enrollment_count":6500,"lead_sponsor_name":"Maja Thiele","has_results":false},{"nct_id":"NCT07248371","title":"Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":6266,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT05423327","title":"Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)","phase":"NA","overall_status":"TERMINATED","enrollment_count":5311,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT06535867","title":"The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study","phase":"","overall_status":"RECRUITING","enrollment_count":5122,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT03149627","title":"Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults","phase":"","overall_status":"COMPLETED","enrollment_count":5003,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT03704402","title":"Effect of High School Alcohol Policies on Students' Binge Drinking- a Natural Experiment","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT05029583","title":"Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"LMC Diabetes & Endocrinology Ltd.","has_results":false},{"nct_id":"NCT05463796","title":"InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT04371042","title":"PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT02938377","title":"Alcohol Research Consortium in HIV-Intervention Research Arm","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":4985,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":true},{"nct_id":"NCT07070362","title":"Digital Early Warning System for Acute Lung Injury in Liver Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Beijing Tsinghua Chang Gung Hospital","has_results":false},{"nct_id":"NCT06512701","title":"Study on the Correlation Between Fat Soluble Vitamins and Non-alcoholic Fatty Liver Disease","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT06357416","title":"The Man Van Project","phase":"NA","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Royal Marsden NHS Foundation Trust","has_results":false},{"nct_id":"NCT04253158","title":"Implementation of a Web-based Alcohol and Other Drug Prevention Intervention for Collegiate Student-athletes","phase":"NA","overall_status":"COMPLETED","enrollment_count":3859,"lead_sponsor_name":"Prevention Strategies, LLC","has_results":false},{"nct_id":"NCT03906500","title":"High Schools- High on Life: an Intervention to Reduce Excessive Drinking in Danish High Schools","phase":"NA","overall_status":"TERMINATED","enrollment_count":3682,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT03396029","title":"Tailored Written Lifestyle Feedback in Colorectal Cancer Screening","phase":"NA","overall_status":"COMPLETED","enrollment_count":3642,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT05281874","title":"Personalized Integrated Alcohol and Sexual Assault Prevention Among College Students","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3300,"lead_sponsor_name":"Georgia State University","has_results":false},{"nct_id":"NCT04150510","title":"Assessment of Smoking, Vaping, and Alcohol Consumption Behavior","phase":"","overall_status":"COMPLETED","enrollment_count":3245,"lead_sponsor_name":"Pennington Biomedical Research Center","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}